American Society of Clinical Oncology

SHERPA: White

People

  1. Ilson
    Ilson
  2. Kelsen
    Kelsen
  3. Vakiani
    Vakiani
  4. Berger
    Berger
  5. Ku
    Ku
  6. Janjigian
    Janjigian
  7. Solit
    Solit
  8. Schattner
    Schattner
  9. Capanu
    Capanu
  10. Chou
    Chou

Groups

  1. Department of Medicine (8)
  2. Gastrointestinal Oncology Service (8)
  3. Solid Tumor Oncology Division (8)
  4. Center for Pancreatic Cancer Research (7)
  5. Epidemiology and Biostatistics (6)
  6. GSK Faculty (6)
  7. Hematologic Malignancies, Division of (6)
  8. Human Oncology and Pathogenesis Program (6)
  9. Biostatistics Service (4)
  10. Genitourinary Oncology Service (4)
Search Within
  1. "David Ilson"
  2. "Yelena Janjigian"
  3. "Efsevia Vakiani"
Formats
  1. Meeting Abstract (8)
Groups
  1. Department of Medicine (8)
  2. Gastrointestinal Oncology Service (8)
  3. Solid Tumor Oncology Division (8)
  4. Center for Pancreatic Cancer Research (7)
  5. Epidemiology and Biostatistics (6)
  6. GSK Faculty (6)

More Groups

People
  1. David Ilson (8)
  2. Efsevia Vakiani (8)
  3. Yelena Janjigian (8)
  4. David Kelsen (7)
  5. Geoffrey Ku (6)
  6. Michael Berger (6)

More People

Years
  1. 2016 (1)
  2. 2015 (3)
  3. 2014 (2)
  4. 2013 (1)
  5. 2012 (1)
Publications
  1. Journal of Clinical Oncology (8)

Results (8)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Emergence of RTK/RAS/PI3K pathway alterations in trastuzumab-refractory HER2-positive esophagogastric (EG) tumors
    Meeting Abstract

    Janjigian, Y. Y.; Sanchez-Vega, F.; Tuvy, Y.; Bouvier, N.; Riches, J. C.; Margolis, M.; Millang, B. M.; Scott, S. N.; Kundra, R.; Castel, P.; more...
    Journal of Clinical Oncology (2016)

    Fulltext@MSK | Save
  • Genomic profiling of esophagogastric (EG) tumors in clinical practice
    Meeting Abstract

    Riches, J. C.; Schultz, N.; Ku, G. Y.; Imtiaz, T.; Kelsen, D. P.; Ilson, D. H.; Solit, D. B.; Berger, M. F.; Ladanyi, M.; Arcila, M. E.; more...
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save
  • Loss of human epidermal growth factor receptor 2 (HER2) expression in HER2-overexpressing esophagogastric (EG) tumors treated with trastuzumab
    Meeting Abstract

    Janjigian, Y. Y.; Riches, J. C.; Ku, G. Y.; Imtiaz, T.; Capanu, M.; Chou, J. F.; Kelsen, D. P.; Ilson, D. H.; Berger, M. F.; Vakiani, E.
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save
  • A phase II study of afatinib in patients (pts) with metastatic human epidermal growth factor receptor (HER2)-positive trastuzumab refractory esophagogastric (EG) cancer
    Meeting Abstract

    Janjigian, Y. Y.; Ku, G. Y.; Ilson, D. H.; Boyar, M. S.; Capanu, M.; Chou, J. F.; Kelsen, D. P.; Imtiaz, T.; Berger, M. F.; Vakiani, E.
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save
  • Patient-derived xenografts as models for the identification of predictive biomarkers in esophagogastric cancer
    Meeting Abstract

    Janjigian, Y. Y.; Vakiani, E.; Imtiaz, T.; Huang, X.; Ilson, D. H.; Rizk, N. P.; Coit, D. G.; Strong, V. E.; de Stanchina, E.
    Journal of Clinical Oncology (2014)

    Fulltext@MSK | Save
  • A phase II study of afatinib in patients (pts) with metastatic human epidermal growth factor receptor (HER2)-positive trastuzumab-refractory esophagogastric (EG) cancer
    Meeting Abstract

    Janjigian, Y. Y.; Capanu, M.; Imtiaz, T.; Kelsen, D. P.; Ku, G. Y.; Schattner, M.; Brown, K. T.; Ilson, D. H.; Solit, D. B.; Berger, M. F.; more...
    Journal of Clinical Oncology (2014)

    Fulltext@MSK | Save
  • A phase II study of afatinib in patients (pts) with metastatic human epidermal growth factor receptor (HER2)-positive trastuzumab-refractory esophagogastric (EG) cancer
    Meeting Abstract

    Janjigian, Y. Y.; Capanu, M.; Gromisch, C. M.; Kelsen, D. P.; Ku, G. Y.; Brown, K. T.; Schattner, M.; Ilson, D. H.; Solit, D. B.; Berger, M. F.; more...
    Journal of Clinical Oncology (2013)

    Fulltext@MSK | Save
  • A phase II study of afatinib (BIBW 2992) in patients with advanced HER2-positive trastuzumab-refractory esophagogastric cancer
    Meeting Abstract

    Janjigian, Y. Y.; Ilson, D.; Kelsen, D. P.; Schattner, M.; Heguy, A.; Vakiani, E.
    Journal of Clinical Oncology (2012)

    Fulltext@MSK | Save